FIELD: chemistry.
SUBSTANCE: invention relates to the somatostatin antagonists which are used in the method of binding one or several somatostatin receptor subtypes -1, -2, -3, -4 and -5 in man and animal, in the method of revealing the somatostatin antagonist effect in man and animal, in the method for stimulating the growth hormone release in man and animal, in the method for stimulating insulin release in man and animal, in the method of enhancing the wound healing in man and animal, in the method for stimulating angiogenesis in man and animal, in the method of treatment of a disease or condition in suffering man or animal, where the said disease or condition is selected from the group consisting of dwarfism, cachexia, emaciation and diabetes II.
EFFECT: treatment of many diseases.
7 cl, 1 dwg, 3 tbl
